AnaptysBio Overview
AnaptysBio Target Price
Analysts' 12-month price predictions for ANAB.
Share Price
$19.59
Average Target Price
$43.67
122.9% upside
122.9% upside3 analysts in the last 4 months
High: $54 | Low: $25
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-06 | GuggenheimYatin Suneja | $54 | 175.7% upside |  |
| 2025-03-03 | Guggenheim | $52 | 165.4% upside | |
| 2025-02-04 | Wolfe ResearchAndy Chen | $25 | 27.6% upside | |
| 2024-12-11 | H.C. WainwrightEmily Bodnar | $19 |  3% downside | |
| 2024-11-06 | H.C. WainwrightEmily Bodnar | $52 | 165.4% upside | |
| 2024-11-06 | Leerink PartnersDavid Risinger | $45 | 129.7% upside | |
| 2024-10-21 | GuggenheimYatin Suneja | $90 | 359.4% upside | |
| 2024-10-15 | Piper SandlerYasmeen Rahimi | $80 | 308.4% upside | |
| 2024-10-03 | New StreetDavid Risinger | $35 | 78.7% upside | |
| 2024-08-15 | Truist FinancialJoon Lee | $30 | 53.1% upside | |
| 2024-04-16 | Leerink PartnersDavid Risinger | $47 | 139.9% upside | |
| 2022-11-18 | J.P. Morgan | $32 | 63.3% upside | |